Eurofins Scientific Shares Gain 2.27% Following Massive Buyback
Eurofins Scientific is making gains this Monday, April 27, 2026, with a share price increase of 2.27% to €63.20 on the CAC 40, which is up by 0.23% during the session. This rebound comes after a challenging week marked by a nearly 9.5% decline over seven days, amid the launch of a new share buyback program by the company.
Seventh Share Buyback Program to Support the Stock
The rebound observed during the session follows the announcement on Saturday, April 25, of the launch of a seventh share buyback program by Eurofins Scientific. This program, which started on Friday, April 24, 2026, covers a maximum volume equivalent to 4.5% of the company's share capital. It directly follows the sixth installment, operational between April 25, 2025, and April 23, 2026. Such operations generally aim to reduce the free float and create a dilutive effect on earnings per share, which can mechanically support the stock price. Despite this initiative, the stock remains under pressure over longer horizons. The share is down 10.81% over three months, while still showing a gain of 17.34% over one year. The upcoming 2026 half-year results, expected on September 18, will be an important milestone to assess the operational trajectory of the bioanalytical services group. In terms of comparable European values, Sanofi is down 0.27% and UCB is down 0.63% during the session. Across the Atlantic, at the close of the day, Lilly (Eli) lost 3.67%, Johnson & Johnson 1.37%, and AbbVie 1.11%.
Technical Signal Still Fragile Despite Today's Bounce
From a technical standpoint, Eurofins Scientific's stock is trading in the lower part of the Bollinger Bands, at 32% of the range defined by a lower bound of €59.36 and an upper bound of €71.33. This position reflects persistent selling pressure, even though today's rebound slightly distances the price from a potential oversold area. The RSI, at 39, remains well below the neutrality zone of 50, confirming the absence of a clear bullish reversal at this stage. The current price of €63.20 is positioned between the identified support at €60.76, tested during the recent pullback, and the resistance at €69.84. The 200-day moving average, at €63.86, acts as a short-term ceiling: a sustained crossing of this threshold would be a first indicator of a rebalancing of the dynamics. The 20-day and 50-day moving averages, at €65.35 and €64.87 respectively, remain above the current price, illustrating the deterioration of the trend initiated in recent weeks.
